Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.
Arda Therapeutics has raised $43.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
Arda Therapeutics's investors include Andreessen Horowitz, Alumni Ventures, Gaingels, Two Sigma Ventures, Indicator Ventures.
Arda Therapeutics is headquartered in San Francisco, United States.
Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.
Arda Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arda Therapeutics — Funding & Investors." VCBacked, October 1, 2024, https://www.vcbacked.co/company/arda-therapeutics. Accessed October 28, 2026.
VCBacked. (2024). Arda Therapeutics — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/arda-therapeutics
{{cite web |title=Arda Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/arda-therapeutics |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated